codexis logo.jpg
Codexis Reports Financial Results for the Third Quarter of 2015
November 04, 2015 16:05 ET | Codexis, Inc.
Records net income of $5.4 million on revenues of $17.4 million Recognizes licensing agreement milestone payments totaling $11.5 million from GSK and Merck Affirms 2015 revenue guidance and...
codexis logo.jpg
Codexis to Hold 2015 Third Quarter Conference Call on November 4
October 28, 2015 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it will report third quarter 2015 financial results...
codexis logo.jpg
Codexis Earns First Technology Transfer Milestone Payment From Merck
October 15, 2015 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it successfully completed Wave 1 of the transfer of its...
codexis logo.jpg
Codexis Earns $6.5 Million Technology Transfer Milestone Payment From GSK
October 08, 2015 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 8, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it successfully completed Wave 2 of the transfer of its...
codexis logo.jpg
Codexis to Present at Upcoming Investment Conferences
September 10, 2015 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces that management...
codexis logo.jpg
Codexis to Present at Rodman & Renshaw Global Investment Conference
September 02, 2015 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces that management...
codexis logo.jpg
Codexis Reports Financial Results for the Second Quarter of 2015
August 11, 2015 16:05 ET | Codexis, Inc.
-- Raises 2015 revenue and gross margin guidance to reflect recent licensing transaction with Merck -- -- Conference call begins at 4:30 p.m. Eastern time today -- REDWOOD CITY, Calif., Aug. 11,...
codexis logo.jpg
Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development Program
August 11, 2015 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it has entered into a collaborative research and...
codexis logo.jpg
Codexis to Hold 2015 Second Quarter Conference Call on August 11
August 04, 2015 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it...
codexis logo.jpg
Codexis Announces CodeEvolver Technology Transfer and License Agreement With Merck
August 03, 2015 16:23 ET | Codexis, Inc.
Codexis to Receive $5 Million in Upfront Payment Codexis to Hold Conference Call on Tuesday, August 4, 2015 at 11:00 a.m. Eastern Time REDWOOD CITY, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) --...